FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4360610870> ?p ?o ?g. }

• W4360610870 abstract "Abstract Background Rifaximin effectively treats symptomatic uncomplicated diverticular disease (SUDD) and has shown eubiotic potential (i.e., an increase in resident microbial elements with potential beneficial effects) in other diseases. This study investigated changes in the fecal microbiome of patients with SUDD after repeated monthly treatment with rifaximin and the association of these changes with the severity of abdominal pain. Methods This was a single-center, prospective, observational, uncontrolled cohort study. Patients received rifaximin 400 mg twice a day for 7 days per month for 6 months. Abdominal pain (assessed on a 4-point scale from 0 [no pain] to 3 [severe pain]) and fecal microbiome (assessed using 16 S rRNA gene sequencing) were assessed at inclusion (baseline) and 3 and 6 months. The Spearman’s rank test analyzed the relationship between changes in the gut microbiome and the severity of abdominal pain. A p-value ≤ 0.05 was considered statistically significant. Results Of the 23 patients enrolled, 12 patients completed the study and were included in the analysis. Baseline abdominal pain levels decreased significantly after 3 (p = 0.036) and 6 (p = 0.008) months of treatment with rifaximin. The abundance of Akkermansia in the fecal microbiome was significantly higher at 3 (p = 0.017) and 6 (p = 0.015) months versus baseline. The abundance of Ruminococcaceae (p = 0.034), Veillonellaceae (p = 0.028), and Dialister (p = 0.036) were significantly increased at 6 months versus baseline, whereas Anaerostipes (p = 0.049) was significantly decreased. The severity of abdominal pain was negatively correlated with the abundance of Akkermansia (r=-0.482; p = 0.003) and Ruminococcacea e (r=-0.371; p = 0.026) but not with Veillonellaceae , Dialister , or Anaerostipes . After 3 months of rifaximin, abdominal pain was significantly less in patients with Akkermansia in their fecal microbiome than in patients without Akkermansia (p = 0.022). Conclusion The eubiotic effect of rifaximin was associated with decreased abdominal pain in patients with SUDD." @default.
• W4360610870 created "2023-03-24" @default.
• W4360610870 creator A5008585719 @default.
• W4360610870 creator A5008683240 @default.
• W4360610870 creator A5026201343 @default.
• W4360610870 creator A5030632895 @default.
• W4360610870 creator A5036836553 @default.
• W4360610870 creator A5046679163 @default.
• W4360610870 creator A5063490638 @default.
• W4360610870 creator A5071917907 @default.
• W4360610870 creator A5077710856 @default.
• W4360610870 date "2023-03-23" @default.
• W4360610870 modified "2023-10-06" @default.
• W4360610870 title "Eubiotic effect of rifaximin is associated with decreasing abdominal pain in symptomatic uncomplicated diverticular disease: results from an observational cohort study" @default.
• W4360610870 cites W1994386346 @default.
• W4360610870 cites W2125894152 @default.
• W4360610870 cites W2131271579 @default.
• W4360610870 cites W2133715751 @default.
• W4360610870 cites W2138196119 @default.
• W4360610870 cites W2152885278 @default.
• W4360610870 cites W2193346577 @default.
• W4360610870 cites W2194277343 @default.
• W4360610870 cites W2267861477 @default.
• W4360610870 cites W2319922781 @default.
• W4360610870 cites W2346400929 @default.
• W4360610870 cites W2519065099 @default.
• W4360610870 cites W2519626614 @default.
• W4360610870 cites W2619155476 @default.
• W4360610870 cites W2724823319 @default.
• W4360610870 cites W2728880756 @default.
• W4360610870 cites W2787697581 @default.
• W4360610870 cites W2903105830 @default.
• W4360610870 cites W2908444178 @default.
• W4360610870 cites W2921531917 @default.
• W4360610870 cites W2941578712 @default.
• W4360610870 cites W2952089115 @default.
• W4360610870 cites W2955984637 @default.
• W4360610870 cites W2972461442 @default.
• W4360610870 cites W2982120600 @default.
• W4360610870 cites W2990142981 @default.
• W4360610870 cites W3004053305 @default.
• W4360610870 cites W3013092300 @default.
• W4360610870 cites W3083131478 @default.
• W4360610870 cites W3125453009 @default.
• W4360610870 cites W3133341741 @default.
• W4360610870 cites W3146002984 @default.
• W4360610870 cites W3165738016 @default.
• W4360610870 cites W3183242223 @default.
• W4360610870 doi "https://doi.org/10.1186/s12876-023-02690-x" @default.
• W4360610870 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36959568" @default.
• W4360610870 hasPublicationYear "2023" @default.
• W4360610870 type Work @default.
• W4360610870 citedByCount "1" @default.
• W4360610870 countsByYear W43606108702023 @default.
• W4360610870 crossrefType "journal-article" @default.
• W4360610870 hasAuthorship W4360610870A5008585719 @default.
• W4360610870 hasAuthorship W4360610870A5008683240 @default.
• W4360610870 hasAuthorship W4360610870A5026201343 @default.
• W4360610870 hasAuthorship W4360610870A5030632895 @default.
• W4360610870 hasAuthorship W4360610870A5036836553 @default.
• W4360610870 hasAuthorship W4360610870A5046679163 @default.
• W4360610870 hasAuthorship W4360610870A5063490638 @default.
• W4360610870 hasAuthorship W4360610870A5071917907 @default.
• W4360610870 hasAuthorship W4360610870A5077710856 @default.
• W4360610870 hasBestOaLocation W43606108701 @default.
• W4360610870 hasConcept C126322002 @default.
• W4360610870 hasConcept C188816634 @default.
• W4360610870 hasConcept C201903717 @default.
• W4360610870 hasConcept C2778271842 @default.
• W4360610870 hasConcept C2778889925 @default.
• W4360610870 hasConcept C2780955771 @default.
• W4360610870 hasConcept C501593827 @default.
• W4360610870 hasConcept C71924100 @default.
• W4360610870 hasConcept C86803240 @default.
• W4360610870 hasConcept C89423630 @default.
• W4360610870 hasConcept C90924648 @default.
• W4360610870 hasConceptScore W4360610870C126322002 @default.
• W4360610870 hasConceptScore W4360610870C188816634 @default.
• W4360610870 hasConceptScore W4360610870C201903717 @default.
• W4360610870 hasConceptScore W4360610870C2778271842 @default.
• W4360610870 hasConceptScore W4360610870C2778889925 @default.
• W4360610870 hasConceptScore W4360610870C2780955771 @default.
• W4360610870 hasConceptScore W4360610870C501593827 @default.
• W4360610870 hasConceptScore W4360610870C71924100 @default.
• W4360610870 hasConceptScore W4360610870C86803240 @default.
• W4360610870 hasConceptScore W4360610870C89423630 @default.
• W4360610870 hasConceptScore W4360610870C90924648 @default.
• W4360610870 hasIssue "1" @default.
• W4360610870 hasLocation W43606108701 @default.
• W4360610870 hasLocation W43606108702 @default.
• W4360610870 hasLocation W43606108703 @default.
• W4360610870 hasOpenAccess W4360610870 @default.
• W4360610870 hasPrimaryLocation W43606108701 @default.
• W4360610870 hasRelatedWork W2100855685 @default.
• W4360610870 hasRelatedWork W2396419780 @default.
• W4360610870 hasRelatedWork W2430285748 @default.
• W4360610870 hasRelatedWork W2475092095 @default.
• W4360610870 hasRelatedWork W2606775707 @default.
• W4360610870 hasRelatedWork W2944101099 @default.
• W4360610870 hasRelatedWork W3010698787 @default.

• next